B.Riley Reiterates Buy Rating on Spruce Biosciences, Inc. (SPRB)

October 5, 2026 5:07 AM

B.Riley analyst Madison El-Saadi reiterated a Buy rating and $160.00 price target on Spruce Biosciences, Inc. (NASDAQ: SPRB).The analyst comments ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found